Clinical Trials Sponsored by Fundación Saldarriaga Concha

Total 94 results

Fundación Saldarriaga Concha
Pontificia Universidad Javeriana; Ministerio de Ciencia, Tecnología e Innovación

Not yet recruiting

Effect of the 3C Model in Students and Teachers From Vaupés, Boyacá and Amazonas

Resilience, Compassion
Inter-American Development Bank
Fundación Saldarriaga Concha; Instituto Departamental de Salud de Nariño; Ministerio...

Unknown

SPOON: Sustained Program for Improving Nutrition - Colombia

Child Obesity | Malnutrition, Child | Exclusive Breast Feeding
Fundación para la Lucha contra las Enfermedades...

Active, not recruiting

Events Exposure as a Trigger of the Clinical Manifestations of Parkinson's Disease

Parkinson Disease | Parkinsonism

Argentina
Fundación para la Lucha contra las Enfermedades...

Completed

Sodium Intake in Multiple Sclerosis (SALT)

Multiple Sclerosis

Argentina
Fundación para la Lucha contra las Enfermedades...
Entelai

Completed

Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology (AIDEN)

Stroke | Delirium | Migraine | Meningitis | Subarachnoid Hemorrhage | Guillain-Barre Syndrome | Trigeminal Neuralgia | Status Epilepticus | Facial Palsy | Vertigo Benign Positional

Argentina
Fundació Institut Germans Trias i Pujol
Fundació Sant Joan de Déu; Fundación FLS de Lucha Contra el Sida, las Enfermedades... and other collaborators

Completed

Assessment of the Psycho-social Impact of COVID-19 Outbreak (COM-COVID)

COVID-19 | Quality of Life | SARS-CoV 2 | Social Distance | Mental Health Wellness 1 | Psychological | SARS (Disease)

Spain
MultiplAI Health Limited
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia

Enrolling by invitation

Whole Blood Transcriptomic Signal According to Coronary Atherosclerotic Plaque Burden Assessed by CT Angiography (CORPLAQ-TRAIT)

Coronary Stenosis | Atherosclerotic Plaque | Aortic Calcification | Calcific Coronary Arteriosclerosis | Coronary Plaque

Argentina
Gerencia de Atención Primaria, Albacete
Fundación para la Investigación Sanitaria en Castilla-La Mancha (FISCAM); Castilla-La...

Unknown

Effect of Plant Sterols on the Lipid Profile of Patients With Hypercholesterolaemia

Hypercholesterolemia
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica

Unknown

Simplification From Tenofovir Plus Lamivudine or Emtricitabine Plus Ritonavir-Boosted-Protease Inhibitor to Ritonavir-Boosted-Atazanavir Plus Lamivudine in Virologically-Suppressed-HIVInfected Adults With Osteopenia (Osteosimply014)

Human Immunodeficiency Virus

Spain
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica

Unknown

Impact of Extremely Early Antiretroviral Therapy to Reduce VIral REservoir and Induce Functional CURE of HIV-1 Infection (VIRECURE)

HIV Infections

Spain
Santiago Gabriel Miriuka
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia

Completed

Detection of Coronary Artery Calcifications by Whole Blood Transcriptome Analyzed by Artificial InTelligence Algorithms (CAC-TRAIT)

Atherosclerosis | Atheroscleroses, Coronary | Atherosclerotic Plaque

Argentina
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica

Not yet recruiting

Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti- HER2-based Neoadjuvant Therapy (ELPIS Trial) (ELPIS)

Mammary Cancer

Spain
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica

Completed

Comparative Study of the Efficacy of Oral Versus Intravenous Hydration as a Preventive Measure of Contrast-induced Nephropathy (CIN) in Patients With Renal Insufficiency (RI) Grade III Under Study Conducting Computed Tomography (CT) (NICIR)

Renal Insufficiency

Spain
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica

Unknown

Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM (RALAM-RollOver)

HIV Infections | HIV Seropositivity | HIV-1-infection

Spain
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica

Unknown

Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen (RALAM-II)

HIV Infections | HIV Seropositivity | HIV-1-infection

Spain
Rafael Correa-Rocha
Instituto de Salud Carlos III; Fundación Familia Alonso

Recruiting

Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Prevent Rejection in Heart Transplant Children (THYTECH)

Heart Transplantation

Spain
Castilla-La Mancha Health Service
Colegio Oficial de Terapeutas Ocupacionales de Castilla - La Mancha; Fundación... and other collaborators

Recruiting

Multifactorial Fall Prevention Program (Dodgers)

Frail Elderly Syndrome

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Recruiting

Alternative Antibiotics for Syphilis

Primary Syphilis | Secondary Syphilis | Early Latent Syphilis

Spain, United Kingdom
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Completed

Study of the Effect of Atorvastatin for Reducing Aging-related Complication in HIV-infected Patients Older Than 45 Years Receiving a Protease Inhibitor-based Regimen Versus a Raltegravir-based Regimen

Aging-related Inflammation in HIV-infected Patients

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Completed

Clinical Trial to Evaluate Pharmacological Interactions Between γ-hydroxybutyrate (GHB) and Cobicistat (GHB_Cobi)

HIV | Pharmacokinetic Interactions

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Completed

Clinical Trial to Evaluate Drug-drug Interactions Between Darunavir/Cobicistat and Etravirine in Hiv- Infected Patients

HIV-1 Infection

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Completed

Assessment of Dolutegravir Removed by Hemodialysis in HIV-infected Patients With End-stage Renal Disease

HIV

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Completed

First Study to Evaluate the Capacity of Maraviroc Drug to Protect Against HIV Infection in Samples of Rectal Mucosa From Healthy Volunteers

HIV

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Completed

Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors

Dyslipidemia | HIV

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Completed

Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study

HIV Infection | Neurocognitive Disturbance

Spain
University of Castilla-La Mancha
Fundacion del Hospital Nacional de Paraplejicos para la Investigacion y la...

Completed

Transcutaneous Spinal Cord Stimulation and Robotic Therapy (tscs_Lokomat)

Spinal Cord Injuries

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Recruiting

Implementation of Out-of-HOspital Administration of the Long-Acting Cabotegravir+Rilpivirine (HOLA)

HIV-1 Infection

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Completed

Genotypic Tropism Testing In Proviral Dna To Guide CCR5 Antagonist Treatment In Subjects With Undetectable HIV-1 Viremia

HIV

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Completed

Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Protease Inhibitors To Dolutegravir In HIV-1-Infected Subjects With Low Bone Mineral Density

HIV-1 Infection

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Completed

Cross-sectional Study of COVID-19 Infection in Hospital Health Personnel

SARS-CoV-2 Infection

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Completed

Pilot Study to Assess the Impact of a Mobile Health Application (App) on Clinical Outcomes and Satisfaction of Older HIV-Infected Patients, as an Emerging Tool for Care, Education and Prevention.

HIV-1 Infection

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Completed

Drug Interactions Between Echinacea Purpurea and Etravirine

HIV

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Completed

Antiretroviral Resistance Detection by Ultrasensitive Pyrosequencing of the HIV-1 Genome and Virological Response to Antiretroviral Rescue Treatment

HIV

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Irs...

Completed

Drug Interactions Between Silimarine and Darunavir/Ritonavir

HIV

Spain
David Garcia Cinca
Fundació Clínic per la Recerca Biomedica; Dr. Christian Dursteler

Unknown

Effect of Cannabinoid (THC / CBD 50%) on Hyperalgesia in Patients With Deep Endometriosis (EdomTHC)

Endometriosis

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...
IrsiCaixa; CEEISCAT

Completed

Viral Clearance and Epidemiological Characteristics in Patients With Monkeypox (MoViE)

Monkeypox

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...
Aelix Therapeutics

Completed

Study to Assess the Safety and Durability of Viral Control Beyond 24 Weeks of Analytical Treatment Interruption After the Administration of Candidate HIV-1 Vaccines DNA.HTI, MVA.HTI and ChAdOx1.HTI or Placebo in Early Treated HIV-1 Positive Individuals (ATI Extension of AELIX-002 Study)

HIV-1 Infection

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...
ViiV Healthcare

Completed

EFFICACY AND SAFETY OF A SIMPLIFICATION STRATEGY BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS OPTIMIZED TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS CARRYING ARCHIVED MULTIDRUG RESISTANCE MUTATIONS

HIV-1 Infection

Spain
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica; Miquel Ferrer - Investigator Coordinator

Unknown

Adequate Duration of Antibiotic Treatment in Community-acquired Pneumonia With High Risk Class and Adequate Initial Clinical Response (2017-001406-15)

Community-acquired Pneumonia

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...
IrsiCaixa; BCN Checkpoint

Active, not recruiting

Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Study

Monkeypox

Spain
Dentaid SL
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la... and other collaborators

Completed

Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 (COVID-19) in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%. (CPC COVID)

SARS-CoV-2 Infection

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...
Merck Sharp & Dohme LLC

Completed

Removal of Doravirine by Hemodialysis in HIV-Infected Patients With End-stage Renal Disease (ESRD)

HIV-infected Participants With ESRD Undergoing Routine Hemodialysis

Spain
Milagros Rocha Barajas
Instituto de Salud Carlos III

Recruiting

Effect of Non-chirurgical Periodontal Treatment on the Immune System From a Gender Perspective

Periodontal Diseases

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...
Merck Sharp & Dohme LLC

Completed

Clinical Trial to Evaluate the Effect of Raltegravir Intensification (1.200 mg QD) on the Gut Microbiota of Chronically HIV-1 Infected Subject Over Time: THE RAGTIME STUDY

HIV

Spain
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV

HIV Infections

Spain
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens

HIV Infections | Hepatitis C

Spain
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy

HIV Infections

Spain
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain

HIV Infections

Spain
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV

HIV Infections

Spain
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV Patients

HIV Infections

Spain

Clinical Trials Sponsored by Fundación Saldarriaga Concha

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations